Research output per year
Research output per year
Fingerprint
Dive into the research topics where Laurens Liesenborghs is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 5 A1: Web of Science-article
-
Antibiotic overuse for COVID-19; are we adding insult to injury?
Abdela, S. G., Liesenborghs, L., Tadese, F., Abegaz, S. H., Bayuh, F. B., Asmamaw, E. A., Mebratie, T. A., Mamo, A. E., Mebrate, M. A., Embiale, W., Hunegnaw, S., Hundie, D. B., Hurissa, Z., Agero, G., Kaso, A. W., van Henten, S. & van Griensven, J., 2021, In : American Journal of Tropical Medicine and Hygiene. 105, 6, p. 1519-1520 2 p.Research output: Contribution to journal › A1: Web of Science-article
-
Early high antibody-titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma
DAWn-plasma investigators, 2021, In : European Respiratory Journal.Research output: Contribution to journal › A1: Web of Science-article
-
Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial
Liesenborghs, L., Spriet, I., Jochmans, D., Belmans, A., Gyselinck, I., Teuwen, L-A., ter Horst, S., Dreesen, E., Geukens, T., Engelen, M. M., Landeloos, E., Geldhof, V., Ceunen, H., Debaveye, B., Vandenberk, B., van der Linden, L., Jacobs, S., Langendries, L., Boudewijns, R., Do, T. N. D. & 19 others, , 2021, In : EBioMedicine. 66, 11 p., 103288.Research output: Contribution to journal › A1: Web of Science-article
Open AccessFile1 Downloads (Pure) -
Venous thromboembolism in patients discharged after COVID-19 hospitalization
Engelen, M. M., Vandenbriele, C., Balthazar, T., Claeys, E., Gunst, J., Guler, I., Jacquemin, M., Janssens, S., Lorent, N., Liesenborghs, L., Peerlinck, K., Pieters, G., Rex, S., Sinonquel, P., Van der Linden, L., Van Laer, C., Vos, R., Wauters, J., Wilmer, A., Verhamme, P. & 1 others, , 2021, In : Seminars in Thrombosis and Hemostasis. 10 p.Research output: Contribution to journal › A1: Web of Science-article
-
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
Devos, T., Geukens, T., Schauvlieghe, A., Ariën, K. K., Barbezange, C., Cleeren, M., Compernolle, V., Dauby, N., Desmecht, D., Grimaldi, D., Lambrecht, B. N., Luyten, A., Maes, P., Moutschen, M., Romano, M., Seyler, L., Nevessignsky, M. T., Vandenberghe, K., van Griensven, J., Verbeke, G. & 5 others, , 2020, In : Trials. 21, 1, 15 p., 981.Research output: Contribution to journal › A1: Web of Science-article
Open AccessFile6 Downloads (Pure)